Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure).

[1]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.

[2]  D. J. Veldhuisen,et al.  Anemia in Heart Failure: Still Relevant? , 2017 .

[3]  S. Blecker,et al.  Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetes , 2016, BMC Cardiovascular Disorders.

[4]  V. Perkovic,et al.  Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis. , 2016, The lancet. Diabetes & endocrinology.

[5]  Deepak L. Bhatt,et al.  Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry , 2015, Circulation.

[6]  Daniala L. Weir,et al.  Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study. , 2014, JACC. Heart failure.

[7]  Deepak L. Bhatt,et al.  Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial , 2014, Circulation.

[8]  Deepak L. Bhatt,et al.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. , 2013, The New England journal of medicine.

[9]  A. Adler,et al.  Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta‐analysis , 2013, European journal of heart failure.

[10]  D. Sacks.  Measurement of Hemoglobin A1c , 2012, Diabetes Care.

[11]  T. Horwich,et al.  Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus. , 2012, The American journal of cardiology.

[12]  J. Shaw,et al.  Current controversies in the use of haemoglobin A1c , 2012, Journal of internal medicine.

[13]  Ramachandran S Vasan,et al.  Diabetes and the risk of heart failure. , 2012, Heart failure clinics.

[14]  P. Heidenreich,et al.  Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure. , 2011, American heart journal.

[15]  J. Coresh,et al.  The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study , 2010, Diabetes.

[16]  B. Bozkurt,et al.  Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. , 2009, Journal of the American College of Cardiology.

[17]  A. Rigby,et al.  Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus , 2009, Heart.

[18]  S. Russell,et al.  HbA1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study , 2008, Diabetologia.

[19]  John M. Lachin,et al.  Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program , 2007 .

[20]  G. Fonarow,et al.  Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2007, American heart journal.

[21]  G. Fonarow,et al.  An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. , 2006, American heart journal.

[22]  Lynn A Smaha,et al.  The American Heart Association Get With The Guidelines program. , 2004, American heart journal.

[23]  R. Gliklich,et al.  Using "get with the guidelines" to improve cardiovascular secondary prevention. , 2003, Joint Commission journal on quality and safety.

[24]  M. Domanski,et al.  The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. , 2003, Journal of the American College of Cardiology.

[25]  M. Drazner,et al.  Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. , 2001, Journal of the American College of Cardiology.

[26]  Jennifer Y. Liu,et al.  Glycemic Control and Heart Failure Among Adult Patients With Diabetes , 2001, Circulation.